REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,261,236 | -37.6% | 1,200 | -47.8% | 0.04% | -74.1% |
| Q4 2023 | $2,020,067 | -29.9% | 2,300 | -34.3% | 0.17% | +30.8% |
| Q3 2023 | $2,880,360 | +133.7% | 3,500 | +133.3% | 0.13% | +118.0% |
| Q1 2023 | $1,232,505 | -77.2% | 1,500 | -80.0% | 0.06% | -79.6% |
| Q4 2022 | $5,411,175 | – | 7,500 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 131,400 | $79,521,000 | 0.09% |
| SIMPLEX TRADING, LLC | 32,800 | $18,847,000 | 0.02% |
| Maven Securities LTD | 500 | $303,000 | 0.01% |
| SG Americas Securities, LLC | 7,100 | $443,000 | 0.00% |
| Allianz Asset Management GmbH | 3,300 | $1,997,000 | 0.00% |
| SUMITOMO MITSUI FINANCIAL GROUP, INC. | 745 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |